---
category: listing
circular_id: 149e77e3f31439b5
date: '2025-12-29'
description: BSE announces upcoming listing of Gujarat Kidney and Super Speciality
  Limited equity shares with scrip code 544666 and symbol GKSL.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={6E0E4D5C-9F8D-428C-9B86-C6DE8F9AF00E}&noticeno=20251229-3&dt=12/29/2025&icount=3&totcount=8&flag=0
impact: low
impact_ranking: low
importance_ranking: medium
justification: Standard new listing announcement with medium importance for investors
  tracking IPOs/new listings, but low market-wide impact as specific listing date
  not yet announced
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251229-3&attachedId=
processing:
  attempts: 1
  content_hash: d79ca824055956bb
  processed_at: '2025-12-29T09:33:41.828793'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-29T06:51:37+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={6E0E4D5C-9F8D-428C-9B86-C6DE8F9AF00E}&noticeno=20251229-3&dt=12/29/2025&icount=3&totcount=8&flag=0
severity: low
source: bse
stocks:
- GKSL
tags:
- listing
- equity-shares
- new-listing
- company-announcement
- GKSL
title: Listing of Equity Shares of Gujarat Kidney and Super Speciality Limited
---

## Summary

BSE has announced that the equity shares of Gujarat Kidney and Super Speciality Limited will be listed and admitted to dealings on the Exchange in due course. The company has been assigned scrip code 544666, trading symbol GKSL, and ISIN number INE0V0W01025. The exact listing date and security details will be communicated through a separate notice.

## Key Points

- Company Name: Gujarat Kidney and Super Speciality Limited
- Scrip Code: 544666
- Trading Symbol: GKSL
- ISIN Number: INE0V0W01025
- Listing will occur on BSE in due course
- Specific listing date to be announced separately

## Regulatory Changes

No regulatory changes. This is a standard listing announcement.

## Compliance Requirements

Trading members of the Exchange are informed about the upcoming listing. No specific compliance actions required at this time. Members should await the subsequent notice with listing date and security details.

## Important Dates

- Notice Date: December 29, 2025
- Listing Date: To be announced through separate notice

## Impact Assessment

This announcement has limited immediate market impact as it is a preliminary notification. The listing will add a new healthcare sector company (kidney and super-specialty services) to BSE's equity segment. Specific impact on trading activity will depend on the company's offering size and investor interest, details of which will be provided in the forthcoming listing notice.